1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 17,300 | 18,000 | 25.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Getinge AB: Resolutions at Getinge's Annual General Meeting April 21, 2026 | 198 | GlobeNewswire (Europe) | Press Release
Gothenburg, Sweden on April 21, 2026
Getinge AB (publ)'s Annual General Meeting ("AGM") was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the... ► Artikel lesen | |
| Di | Getinge AB Non-GAAP EPS of SEK 1.80; maintains FY26 forecast of organic sales growth | 2 | Seeking Alpha | ||
| Di | Getinge AB Reveals Increase In Q1 Bottom Line | 320 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST) revealed a profit for its first quarter that Increases, from the same period last yearThe company's bottom line came in at SEK402 million, or SEK1.47... ► Artikel lesen | |
| Di | Getinge AB: Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone | 126 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on April 21, 2026
"We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos... ► Artikel lesen | |
| GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
| 08.04. | Getinge acquires Pennamed to strengthen endoscopy offering in the UK | 7 | Cision News | ||
| 07.04. | Getinge invites fund managers, analysts, and media to Q1 Report 2026 conference call | 3 | Cision News | ||
| 26.03. | Getinge publishes Annual Report for 2025 | 227 | PR Newswire | GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked... ► Artikel lesen | |
| 24.03. | Getinge Advances ECLS Technology with Cardiohelp II - The Next Evolution in Extracorporeal Life Support | 2 | Cision News | ||
| 18.03. | Getinge's iCast covered stent system expands U.S. offering with additional sizes | 5 | Cision News | ||
| 12.03. | NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL) | 3 | Cision News | ||
| 02.02. | Getinge Q4 2025: Gewinn übertrifft Erwartungen, Umsatz und Aktie unter Druck | 8 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 2025: Organisches Wachstum trotz Währungs- und Zollbelastungen | 2 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 2025 slides: organic growth persists amid FX and tariff headwinds | 1 | Investing.com | ||
| 27.01. | Getinge im vierten Quartal 2025: Währungs- und Zolleffekte schmälern die Marge | 5 | Investing.com Deutsch | ||
| 27.01. | Getinge Q4 Net Profit Up, But Sales & Order Intake Down; Sees Organic Sales Growth In FY26 | 421 | AFX News | STOCKHOLM (dpa-AFX) - Swedish medical technology company Getinge AB (GNGBF, GETI-B.ST) on Tuesday reported higher net profit in its fourth quarter, despite weak net sales. Order intake also... ► Artikel lesen | |
| 27.01. | Getinge AB Q4 Profit Climbs | 411 | AFX News | STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at SEK868 million, or SEK3.19... ► Artikel lesen | |
| 27.01. | Getinge AB Non-GAAP EPS of SEK 4.45, revenue of SEK 10.19B; initiates FY26 outlook | 3 | Seeking Alpha | ||
| 27.01. | Getinge AB: Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year | 335 | GlobeNewswire (Europe) | Press release
Gothenburg, Sweden on January 27, 2026
"We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for... ► Artikel lesen | |
| 13.01. | Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call | 14 | Cision News | ||
| 19.12.25 | Getinge transforms sterile reprocessing with Automatiq - a full range of logistic automation modules | 8 | Cision News |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,840 | -0,44 % | DEUTSCHE BANK RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für FMC mit einem Kursziel von 42 Euro auf "Hold" belassen. Der Dialysekonzern dürfte dank temporärer Faktoren solide ins Jahr... ► Artikel lesen | |
| ESSILORLUXOTTICA | 187,00 | -0,16 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für EssilorLuxottica von 250 auf 185 Euro gesenkt, aber die Einstufung auf "Market-Perform" belassen. In den vergangenen... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 160,10 | -1,08 % | Piper Sandler raises Align Technology stock price target on volume growth | ||
| INMODE | 12,265 | -0,16 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| ELEVANCE HEALTH | 294,70 | +0,17 % | Elevance Health Revises Annual Earnings Guidance | WASHINGTON (dpa-AFX) - Elevance Health, Inc. (ELV) on Wednesday revised its annual earnings outlook. Gail K. Boudreaux, CEO of Elevance Health, said: 'We are raising our full-year adjusted EPS... ► Artikel lesen | |
| BONESUPPORT | 21,860 | +0,28 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q1 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the first quarter 2026.
"Solid start to 2026 - strong growth... ► Artikel lesen | |
| TENET | 151,00 | -1,95 % | Cantor Fitzgerald bestätigt Rating für Tenet Healthcare aufgrund von Volumendaten | ||
| ARJO | 2,344 | +1,21 % | Dividendenbekanntmachungen (23.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AENA SME SA ES0105046017 - 1,09 EUR AKER ASA NO0010234552 29 NOK 2,6622 EUR ALFA LAVAL AB SE0000695876 9 SEK 0,8348 EUR ARJO... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 17,100 | +4,91 % | AMN Healthcare Services Inc: AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results | Quarterly revenue of $748 million- GAAP loss of ($0.20)/share and adjusted EPS of $0.22DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator... ► Artikel lesen | |
| OSSDSIGN | 0,404 | -0,49 % | OssDsign AB: OssDsign provides pre-release update on Q1 2026 performance | OssDsign AB (publ.) today announces that preliminary revenue for the period January - March, 2026 will be USD 4.035 million or SEK 36.880 million. The company attributes these results to a lack of... ► Artikel lesen | |
| ALPHATEC | 9,000 | -3,23 % | Alphatec Holdings, Inc. and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion | ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering... ► Artikel lesen | |
| CHECK-CAP | 1,300 | 0,00 % | Humanoid Global gibt strategische Investition in MBody AI, Entwickler einer Autonomieplattform für verkörperte KI bekannt | - NICHT ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN ODER ÜBER US-NACHRICHTENDIENSTE BESTIMMT -
Vancouver, BC und Las Vegas, Nevada - 7. Januar 2026 / IRW-Press / Humanoid Global
... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 17,700 | -1,12 % | Dividendenbekanntmachungen (03.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV BE0974264930 - 1,5 EUR ALIMENTATION COUCHE-TARD INC CA01626P1484 0,215 CAD 0,1323 EUR AMKOR TECHNOLOGY INC US0316521006 0... ► Artikel lesen | |
| CROSS COUNTRY HEALTHCARE | 8,450 | +1,20 % | Cross Country Healthcare names Darrick Sogabe chief product officer |
GETINGE AB ADR gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,800 (-4,47 %) liegt der Kurs bei 17,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GETINGE AB ADR finden Sie auf Wallstreet Online.